We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTN
4001
Palatin Technologies
PTN
$13.7M
$21K ﹤0.01%
+37
New +$19.3K
SONM icon
4002
DNA X Inc
SONM
$5.05M
$21K ﹤0.01%
134
-488
-78% -$66.1K
ZCMD icon
4003
Zhongchao
ZCMD
$6.96M
$21K ﹤0.01%
2
TIO
4004
DELISTED
Tingo Group, Inc. Common Stock
TIO
$21K ﹤0.01%
+33,800
New +$23.2K
KBNT
4005
DELISTED
Kubient, Inc. Common Stock
KBNT
$20K ﹤0.01%
+11,700
New +$25.5K
CBUS icon
4006
Cibus
CBUS
$147M
$19K ﹤0.01%
358
-1,270
-78% -$94.9K
JOB icon
4007
GEE Group
JOB
$23.1M
$19K ﹤0.01%
+34,200
New +$18.7K
LPCN icon
4008
Lipocine
LPCN
$17.5M
$19K ﹤0.01%
+829
New +$17.3K
WNW icon
4009
Meiwu Technology Co
WNW
$3.33M
0
AIH
4010
DELISTED
Aesthetic Medical International Holdings
AIH
$19K ﹤0.01%
11,900
-1,400
-11% -$3.95K
CMPX icon
4011
Compass Therapeutics
CMPX
$344M
$18K ﹤0.01%
+13,300
New +$27.5K
UPC icon
4012
Universe Pharmaceuticals Inc
UPC
$2.05M
$18K ﹤0.01%
4
-2
-33% -$10.1K
ASPU
4013
DELISTED
ASPEN GROUP, INC.
ASPU
$18K ﹤0.01%
11,100
-130,831
-92% -$224K
AGPU
4014
Axe Compute Inc
AGPU
$95.4M
$15K ﹤0.01%
50
-734
-94% -$195K
SPCB icon
4015
SuperCom
SPCB
$67.3M
$15K ﹤0.01%
+133
New +$14.8K
NVCN
4016
DELISTED
Neovasc Inc.
NVCN
$15K ﹤0.01%
1,416
-4,304
-75% -$48K
EXN
4017
DELISTED
Excellon Resources Inc.
EXN
$15K ﹤0.01%
+16,500
New +$13.8K
EVOK
4018
DELISTED
Evoke Pharma
EVOK
$14K ﹤0.01%
196
-120
-38% -$9.57K
PLX icon
4019
Protalix BioTherapeutics
PLX
$191M
$13K ﹤0.01%
+11,900
New +$10.9K
SNTG icon
4020
Sentage Holdings
SNTG
$4.6M
$13K ﹤0.01%
+2,480
New +$11.3K
CNET icon
4021
ZW Data Action Technologies
CNET
$5.87M
$12K ﹤0.01%
830
-2,800
-77% -$43K
JFU
4022
9F Inc
JFU
$23.9M
$12K ﹤0.01%
685
-355
-34% -$7.24K
KRKR
4023
36Kr Holdings
KRKR
$5.68M
$12K ﹤0.01%
+540
New +$10.1K
BQ
4024
Boqii Holding Ltd
BQ
$5.87M
$11K ﹤0.01%
+122
New +$15.6K
QH
4025
Quhuo Limited Class A Ordinary Shares
QH
$15.5K
$11K ﹤0.01%
20
-20
-50% -$14K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.